Diabetes Archive

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance who were at low risk of cardiovascular events.

Dementia Risk Reduced With Metformin in Veterans With T2D

Dementia Risk Reduced With Metformin in Veterans With T2D

Metformin is linked to a lower dementia risk compared to sulfonylureas among veterans with type 2 diabetes.

Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i

Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i

Researchers evaluated a meta-analysis of randomized controlled trials and an analysis of the FDA AE Reporting System to determine whether combination DPP4i/SGLT2i medication lowers risk of GUTI.

Efficacy of Oral and Subcutaneous Semaglutide in T2D

Efficacy of Oral and Subcutaneous Semaglutide in T2D

All dosages of oral semaglutide reduced mean HbA1c level significantly more than placebo by week 26.

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

People with type 2 diabetes and NOCS-NSTEMI who used incretin had a better prognosis than non-incretin users.

Lower-Quality Diabetes Care Seen in Patients With Schizophrenia

Lower-Quality Diabetes Care Seen in Patients With Schizophrenia

Among patients with schizophrenia, documented drug abuse and low contact volume of the diabetes clinic were associated with low-quality diabetes care.

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.

Glucose Patterns and the Future Development of Diabetes

Glucose Patterns and the Future Development of Diabetes

Study revealed heterogeneity in plasma glucose response to oral glucose intake beyond the established glucose criteria based on fasting plasma glucose and 2 h post-load plasma glucose levels.

Examining the Benefits of Statins, ACE Inhibitors in T1D With Albumin Excretion

Examining the Benefits of Statins, ACE Inhibitors in T1D With Albumin Excretion

Lower incidence of microalbuminuria was noted with the use of ACE inhibitors vs placebo.

Does Serum Vitamin D in Pregnancy Alter T1D Development Risk in Children?

Does Serum Vitamin D in Pregnancy Alter T1D Development Risk in Children?

Study finds for the first time that during pregnancy the associations between serum 25OHD concentration and 2 single nucleotide polymorphisms are stronger in mothers of children with T1D.

Gestational Diabetes Associated With Adiposity, Puberty Onset in Offspring

Gestational Diabetes Associated With Adiposity, Puberty Onset in Offspring

Researchers assessed the impact of maternal gestational diabetes on insulin resistance and adiposity in adolescent offspring.

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.

Rate of Undiagnosed Diabetes in the United States

Rate of Undiagnosed Diabetes in the United States

Undiagnosed diabetes is a relatively small fraction of the total diabetes population when a confirmatory definition is used.

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Patient Nonadherence Often Misidentified as Diabetes Treatment Failure

Second-line treatments are often initiated without first using first-line therapies.

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Studies have not previously examined long-term risks or mortality after aortic aneurysm or dissection in people with type 2 diabetes.

T2D and Magnesium Intake: Risk of Incident Diabetes Examined

T2D and Magnesium Intake: Risk of Incident Diabetes Examined

Higher magnesium intake was linked to a 15% lower risk for type 2 diabetes.

Cognitive Status in T2D: Retinal Sensitivity Predictive of Neurodegeneration

Cognitive Status in T2D: Retinal Sensitivity Predictive of Neurodegeneration

Retinal sensitivity, assessed by microperimetry, is related to brain neurodegeneration in T2D.

Diabetes Following Pancreatic Disease Often Misclassified as T2D

Diabetes Following Pancreatic Disease Often Misclassified as T2D

Diabetes following pancreatic disease often requires higher use of insulin and worse glycemic control.

Ventricular Function With Vildagliptin in T2D and CHF

Ventricular Function With Vildagliptin in T2D and CHF

Study highlights the need to examine the safety of new glucose-lowering treatments specifically in patients with diabetes and heart failure and reduced ejection fraction.

DPP4-i Plus α-Glucosidase Inhibitor Reduces HbA1c in T2D

DPP4-i Plus α-Glucosidase Inhibitor Reduces HbA1c in T2D

People with T2D experienced greater HbA1c reductions with the addition of a DPP4 inhibitor vs placebo.

SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents

SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents

A recent population-based study is the first to examine the risk of type 2 diabetes associated with the use of antidepressant medication in children and adolescents.

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

Based on glycemic control and treatment method, type 2 diabetes in the heart failure population can be indicative of various risk associations.

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Heart failure prevention may be an opportunity to reduce the risk of death in specific cardiovascular subcategories.

FDA Approves Exenatide Extended-Release Injection for T2D

FDA Approves Exenatide Extended-Release Injection for T2D

The new formulation of Bydureon BCise allows for once-weekly administration with an autoinjector pen.

Improved Outcomes in Prediabetes, T2D With Liraglutide

Improved Outcomes in Prediabetes, T2D With Liraglutide

The efficacy of liraglutide therapy was examined in metformin-treated subjects with obesity.

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

Greater prognostic advantages were associated with high-dose beta blockers in chronic heart failure with diabetes.

Reducing HbA1c in T1D and T2D With Flash Glucose Monitoring

Reducing HbA1c in T1D and T2D With Flash Glucose Monitoring

Overall reduction in HbA1c was higher in people with T2D vs those with T1D.

T2D Therapies: Tofogliflozin Efficacy With High Baseline Insulin

T2D Therapies: Tofogliflozin Efficacy With High Baseline Insulin

HbA1c, fasting plasma glucose, and body weight were significantly reduced in all patients taking tofogliflozin.

Heart Failure Outcomes: Worse Long-Term Prognosis in Diabetes

Heart Failure Outcomes: Worse Long-Term Prognosis in Diabetes

Ten-year heart failure outcomes were worse in patients with diabetes than without.

Do Financial Incentives Increase Glucose Monitoring in Teens With T1D?

Do Financial Incentives Increase Glucose Monitoring in Teens With T1D?

Daily financial incentives improved glucose monitoring, but not glycemic control.

Trick or Treat: Tips for Diabetes Management on Halloween

Trick or Treat: Tips for Diabetes Management on Halloween

With a little communication, children with diabetes can still enjoy Halloween festivities.

Examining Melancholia and Atypical Depression in T1D and T2D

Examining Melancholia and Atypical Depression in T1D and T2D

Twenty-five percent of people with type 2 diabetes and 12% of people with type 1 diabetes had depression.

VA, DoD Release New T2D Clinical Practice Guideline

VA, DoD Release New T2D Clinical Practice Guideline

The update provides guidance within 7 areas of type 2 diabetes management, including patient centered care and individualized treatment plans.

ADA Position Statement Update: Hypertension Management in Diabetes

ADA Position Statement Update: Hypertension Management in Diabetes

The latest ADA hypertension position statement incorporates advances in care since 2003.

Evolocumab May Decrease Cardiovascular Risk in Patients With and Without Diabetes

Evolocumab May Decrease Cardiovascular Risk in Patients With and Without Diabetes

PCSK9 inhibition with evolocumab might be an attractive therapy in patients with diabetes, and no discernible effect on glycaemia.

Insulin Plus Sulfonylurea, Metformin Linked to HbA1c Reduction

Insulin Plus Sulfonylurea, Metformin Linked to HbA1c Reduction

However, sulfonylurea plus insulin was linked to more hypglycemic events than insulin alone.

Preventing T2D With Referral to Commercial Weight Management Program

Preventing T2D With Referral to Commercial Weight Management Program

Referral to a commercial weight management program, such as Weight Watchers, can be effective in preventing diabetes.

Mortality in Diabetes Linked to Caffeine Consumption

Mortality in Diabetes Linked to Caffeine Consumption

Caffeine consumed from coffee or tea impacted both cardiovascular and cancer-related mortality in women with diabetes.

Insulin Pump Associated With Fewer Complications Than Injections in Children, Adolescents

Insulin Pump Associated With Fewer Complications Than Injections in Children, Adolescents

Although the incidence of severe hypoglycemia has decreased while insulin pump use has increased, a causal relationship has not been established between insulin administration methods and risk of complications from diabetes.

Treatment Options for Diabetic Neuropathic Pain

Treatment Options for Diabetic Neuropathic Pain

Painful diabetic neuropathy affects approximately one-quarter of people with diabetes.

T2D Remission, Weigh Loss Associated With Roux-en-Y Surgery

T2D Remission, Weigh Loss Associated With Roux-en-Y Surgery

Researchers have identified lasting benefits for patients with severe obesity who undergo Roux-en-Y gastric bypass surgery.

Efficacy of Continuous Glucose Monitoring in Preterm Infants

Efficacy of Continuous Glucose Monitoring in Preterm Infants

Although continuous glucose monitoring accuracy and safety in preterm infants has been validated in several studies, this approach has never been studied in neonates.

Medicare Recipients Overtreated for Diabetes

Medicare Recipients Overtreated for Diabetes

For medicare recipients it is more common to be overtreated than undertreated for diabetes.

AMA: Encouraging Patients to Explore Diabetes Risk Through Tablet Use

AMA: Encouraging Patients to Explore Diabetes Risk Through Tablet Use

One clinic shares results after replacing magazines with tablets allowing patients to examine their risk of developing diabetes.

SPRINT Update: Positive CVD Outcomes With Intensive Blood Pressure Management in Prediabetes

SPRINT Update: Positive CVD Outcomes With Intensive Blood Pressure Management in Prediabetes

Patients with prediabetes who experienced intensive blood pressure management had better outcomes with CVD events and all-cause mortality.

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Liraglutide plus usual care resulted in lower rates of diabetic kidney disease-specific outcomes in type 2 diabetes.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Researchers identified several novel plasma biomarkers that can be used to predict rapid decline in renal function in T2D, independent of traditional risk factors.

Diabetes Self-Management Class Participation Varies in Adults with T2D

Diabetes Self-Management Class Participation Varies in Adults with T2D

Clinicians should identify barriers to patient participation in diabetes self-management classes.

Examining Inclusion of T2D Medication Adherence Data in Studies

Examining Inclusion of T2D Medication Adherence Data in Studies

Results suggest that medication adherence is associated with reduced risk of all-cause mortality in T2D.

Predicting Adult MetS, T2D, CV Risks in Childhood

Predicting Adult MetS, T2D, CV Risks in Childhood

BMI measurement alone can also be used to determine associations between childhood and adulthood conditions.

Efficacy of Hyperbaric Oxygen Therapy in Diabetic Foot Ulcers

Efficacy of Hyperbaric Oxygen Therapy in Diabetic Foot Ulcers

The efficacy and safety profile of hyperbaric oxygen therapy remains controversial because of conflicting data and small sample sizes in clinical trials.

Post-Bariatric Hypoglycemia Effectively Treated by Subcutaneous Exendin

Post-Bariatric Hypoglycemia Effectively Treated by Subcutaneous Exendin

Subcutaneous exendin is safe and effective in treating post-bariatric hypoglycemia.

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

Validation-tool identified "high risk" patients were more likely to report hypoglycemia episodes and subsequent emergence department use.

High Risk of Diabetic Ketoacidosis With Diabetes Presentation in Infancy

High Risk of Diabetic Ketoacidosis With Diabetes Presentation in Infancy

Diabetes in infancy has different characteristics depending on mutation subtype, and is associated with high frequency of diabetic ketoacidosis.

Long-term Mortality Rates After Gastric Bypass in Diabetic Patients

Long-term Mortality Rates After Gastric Bypass in Diabetic Patients

There is reduced mortality for patients with diabetes undergoing RYGB.

HbA1c vs Fasting Plasma Glucose for Prediabetes, Diabetes Diagnosis

HbA1c vs Fasting Plasma Glucose for Prediabetes, Diabetes Diagnosis

The efficacy of diagnosing diabetes or prediabetes using fasting plasma glucose vs traditional HbA1c test was examined.

Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes

Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes

There is improved neonatal outcomes for pregnant women with T1D who use CGM.

Addressing Psychological Insulin Resistance in Patients With Diabetes

Addressing Psychological Insulin Resistance in Patients With Diabetes

Learn about strategies to reduce a patient's reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.

Second-Generation Antipsychotics: Is Diabetes Risk Increased in Children and Adolescents?

Second-Generation Antipsychotics: Is Diabetes Risk Increased in Children and Adolescents?

The study included over 45,000 children using second-generation antipsychotic medications between 2009 and 2013.

Drug Label Updated to Include Time Action Profile for Rapid-Acting Inhaled Insulin

Drug Label Updated to Include Time Action Profile for Rapid-Acting Inhaled Insulin

The prescribing information for Afrezza has been updated to include new clinical data relating to treatment effect and dosing.

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia.

Self-Monitoring Blood Glucose Test Adherence Poor Among Women

Self-Monitoring Blood Glucose Test Adherence Poor Among Women

Only about 60% of women with newly diagnosed gestational diabetes mellitus perform ≥80% of required self-monitoring of blood glucose tests.

Preclinical Study Looks for T2D Links to Pancreas Protein

Preclinical Study Looks for T2D Links to Pancreas Protein

Amyloid polypeptide deposits in the pancreas may lead scientists to a better understanding of type 2 diabetes.

Peptide Immunotherapy for Type 1 Diabetes: A Promising New Treatment

Peptide Immunotherapy for Type 1 Diabetes: A Promising New Treatment

Peptide immunotherapy may offer a personalized approach to modulating the immune response in persons with type 1 diabetes.

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Poorly Controlled Rheumatoid Arthritis Increases T2D Risk

Poorly Controlled Rheumatoid Arthritis Increases T2D Risk

Type 2 diabetes is significantly underdiagnosed and undertreated in patients with rheumatoid arthritis.

Following Ischemic Stroke, Glycemic Control Indicative of Short-Term Outcomes

Following Ischemic Stroke, Glycemic Control Indicative of Short-Term Outcomes

Hyperglycemia treatment was left to physician's discretion.

Availability of Insulin Lispro Injection to Treat Diabetes

Availability of Insulin Lispro Injection to Treat Diabetes

Approved in June 2017, the Humalog Junior KwikPen will soon be available to treat patients with diabetes.

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Patients with MACE showed a greater extent of more severe coronary artery disease.

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Researchers examined how adipocyte size reduction and fatty acid metabolism contribute to remission in type 2 diabetes following bariatric surgery.

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Diacerein was well-tolerated among trial participants, and may be an acceptable adjunct treatment in type 2 diabetes.

Counseling vs Standard Care to Increase Physical Activity in T2D

Counseling vs Standard Care to Increase Physical Activity in T2D

Three hundred physically inactive or sedentary patients received either theoretical and practical counseling once-yearly for 3 years, or standard care.

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

PCI has been linked to increased risk of CHD, mortality, MI, and repeat revascularization in type 1 diabetes.

T1D Risk Increased Following Influenza A H1N1 Diagnosis in Children

T1D Risk Increased Following Influenza A H1N1 Diagnosis in Children

The 2009 H1N1 swine flu pandemic has been linked to an increased risk of new-onset type 1 diabetes in children.

Glycemic Control in Physically Active Adolescents With T1D: Closed-Loop Control vs Remote Pump in Winter Sports

Glycemic Control in Physically Active Adolescents With T1D: Closed-Loop Control vs Remote Pump in Winter Sports

During a 5-day ski camp, researchers examined closed-loop insulin management vs a remote monitored pump system for glycemic control with the additional challenge of cold and altitude.

Cardiovascular, Renal Outcomes in Type 1 Diabetes

Cardiovascular, Renal Outcomes in Type 1 Diabetes

More awareness for afib risk factors including age, severity of complications, and glycemic status are needed.

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Researchers identified strong inverse graded relationships between children's sleep duration, adiposity, and the presence of diabetes risk markers.

ADA Standard of Medical Care in Diabetes 2017 Update

ADA Standard of Medical Care in Diabetes 2017 Update

The ADA 2017 Standards of Medical Care in Diabetes focuses on monitoring and pharmacologic approaches for type 1 diabetes management.

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

A retrospective analysis examined outcomes in patients with type 2 diabetes treated with SGLT2 vs DPP4 inhibitors.

Can Sustained Weight Loss Lead to Remission of T2D?

Can Sustained Weight Loss Lead to Remission of T2D?

Weight loss in people with type 2 diabetes is associated with extended life expectancy.

Population at Risk: CVD Events Increased in Metabolically Healthy Obese

Population at Risk: CVD Events Increased in Metabolically Healthy Obese

Researchers created body size phenotypes, defined by BMI category, to assess CVD incidence in a metabolically healthy obese population.

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Women with atrial fibrillation and diabetes had a higher risk for mortality and cardiovascular complications compared with men.

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

Researchers examined the efficacy of cognitive behavioral group therapy on preventing weight regain or modifying cardiovascular risk factors and psychological well-being.

Examining Cold-Related Cardiorespiratory Symptoms in T2D

Examining Cold-Related Cardiorespiratory Symptoms in T2D

Worsening glycemic status is linked to increased reports of individual cardiorespiratory symptoms, including dyspnea, cough, chest pain, and arrythmia.

Genetic Influence for Late-In-Life T1D Examined

Genetic Influence for Late-In-Life T1D Examined

High-risk genotypes represent 6.4% of the included study population, but accounted for 61% of all cases of T1D.

Does PCOS Increase T2D Event Rate?

Does PCOS Increase T2D Event Rate?

Among women with polycystic ovary syndrome, type two diabetes was more common and diagnosed at a younger age than in control groups.

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Study results support an additional management method for glycemic control in patients with T2D.

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

Researchers examined the efficacy of lifestyle intervention on glycemic control in type 2 diabetes.

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

Over 150 variables were identified as possible hypoglycemia risk factors.

Comparing Early, Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

Comparing Early, Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

An early invasive strategy in patients with non-ST-elevation acute coronary syndromes does not necessarily reduce mortality compared with a delayed strategy.

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD on the risk of developing T2D.

Treatment Delays in T2D Increase Cardiovascular Biomarkers

Treatment Delays in T2D Increase Cardiovascular Biomarkers

Serum NT-proBNP and serum hsTnl levels were examined at baseline, 26, 52, and 104 weeks.

Ipragliflozin vs Pioglitazone for NAFLD in T2D

Ipragliflozin vs Pioglitazone for NAFLD in T2D

Ipragliflozin showed "equally beneficial effects" on glycemic control in patients with nonalcoholic fatty liver disease and type 2 diabetes.

GSK Announces Discontinuation of Injectable Therapy for T2D

GSK Announces Discontinuation of Injectable Therapy for T2D

GlaxoSmithKline expects Tanzeum supplies to be depleted by July 2018.

FDA: Liraglutide Approved for MACE in T2D With Established CVD

FDA: Liraglutide Approved for MACE in T2D With Established CVD

Approval for the new indication follows a review of the results of the LEADER trial.

Neonatal Hypoglycemia Rates in Glyburide vs Insulin Treatment for Gestational Diabetes

Neonatal Hypoglycemia Rates in Glyburide vs Insulin Treatment for Gestational Diabetes

Ten randomized controlled trials were examined to determine the efficacy and safety of glyburide vs insulin treatment for gestational diabetes.

Sign Up for Free e-Newsletters

CME Focus